[Effects of roxithromycin on experimental otitis media].
Shimane
T
T
Asano
K
K
Mizutani
T
T
Hisamitsu
T
T
Suzaki
H
H
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D003864:Depression, Chemical; D005122:Exudates and Transudates / Q000166:cytology / Q000378:metabolism; D019041:L-Selectin / Q000378:metabolism; D008070:Lipopolysaccharides; D008297:Male; D020556:Neutrophil Infiltration / Q000187:drug effects; D010033:Otitis Media / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology*; D051381:Rats; D011916:Rats, Inbred F344; D015575:Roxithromycin / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D016207:Cytokines; D008070:Lipopolysaccharides; D019041:L-Selectin; D015575:Roxithromycin